期刊文献+

2型糖尿病药物磷酸西他列汀的合成 被引量:1

Synthesis of the type 2 anti-diabetic drug sitagliptin phosphate
原文传递
导出
摘要 目的:研究磷酸西他列汀的合成新方法。方法:以2,4,5-三氟苯乙酸和2,2-二甲基-1,3-二噁烷-4,6-二酮为起始原料经10步反应合成了目标产物磷酸西他列汀。结果与结论:目标产物结构经1H-NMR,13CNMR和EI-MS确证,总产率为33%。该合成路线具有原料价廉易得、反应条件温和、收率高的特点,具有较好的工业化应用前景。 Objective: To investigate the new synthetic method of sitagliptin phosphate, a type Ⅱ anti-diabetic drug. Methods : Using 2,4,5-trifluorophenylacetic acid and 2,2-dimethyl-1,3-dioxane-4,6-dione as starting materials, sitagliptin phosphate was synthesized through 10 steps. Results and Conclusion: The structure of target product was characterized by ^1H-NMR, ^13C-NMR and EI-MS. The overall yield was 33%. This synthetic method has advantages such as cheap and easily available material, mild reaction conditions, high yield and simple operation, which is suitable for the large-scale production.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第13期1574-1578,共5页 Chinese Journal of New Drugs
基金 国家级大学生创新创业训练计划(201210337009)
关键词 磷酸西他列汀 抗糖尿病药物 手性中间体 不对称合成 sitagliptin phosphate anti-diabetic drug chiral intermediate asymmetric synthesis
  • 相关文献

参考文献11

  • 1SBOKOVA E, CHRIST AD, BOEHRINGER M, et al. Dipepti- dyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type Ⅱ diabetes [ J ]. Curr Top Med Chem, 2007, 7(6) : 547 -555.
  • 2DRUCKER D, EASLEY C, KIRKOATRICK P. Sitagliptin[ J ]. Nat Rev Drug Discov, 2007, 6(2) : 109 - 110.
  • 3HANSEN KB, BALSELLS J, DREHER S, et al. First genera- tion process for the preparation of the DPP-Ⅳ inhibitor sitagliptin [J]. OrgProRes Dev, 2005, 9(5): 634 -639.
  • 4WU SL, YU B, WANG YJ, et al. Process and intermediates for the preparattion of N-acylated-4-aryl-amino acid derivatives: WO 2010078440[ P]. 2010 -08 -07.
  • 5ANGELAUD R, ARMSTRONG JD, ASKIN D, et al. Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-Ⅳ inhibitors:WO 2004087650[ P]. 2004 - 10 - 14.
  • 6KIM D, WANG LP, BECONI M. (2R)-4-Oxo-4-[ 3-( triflu- oromethyl)-5,6-dihydro [ 1,2,4 I triazolo [ 4, 3-a ] pyrazin-7 ( 8 H ) -yl ] -1 - ( 2,4,5 -trifluorophenyl ) butan-2-amine : a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type2 diabetes[J]. JMed Chem, 2005, 48( 11): 141 -151.
  • 7HSIAO Y,RIVERA NR,ROSNER T,et al. Highly efficient syn- thesis of 13-amino acid derivatives via asymmetric hydrogenation of unprotected enamines[J]. J Am Chem Soc, 2004, 126(10) : 9918 -9919.
  • 8HASEGAWA PA. Combination of a dipeptidyl peptidase-4 inhibi- tor and antihypertensive agent for the treatment of diabetes and hypertension : WO 2007050485 [ P ]. 2007 - 05 - 03.
  • 9CYPES SH, CHEN AM, FERLITA RR, et al. Phosphoric acid salt of a depeptidyl peptidase . Ⅳ inhibitor: WO 2005003135 [P]. 2005-01-13.
  • 10SAVILE CK, JANEY JM, MUNDORFF EC, et al. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture [ J ]. Science, 2010, 329 ( 16 ) : 305 - 309.

同被引文献8

  • 1丁明,姜涛.治疗2型糖尿病新药--磷酸西他列汀[J].中国药房,2008,19(1):58-60. 被引量:9
  • 2SBOKOVA E,CHRIST AD,BOENRINGE M,et al. Dipepti- dyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type II diabetes [ J ]. Curr Top Med Chem, 2007, 7(6) : 547 -555.
  • 3DRUCKER D, EASLEY C, KIRKOATRICK P. Sitagliptin[ J]. Nat Rev Drug Discover, 2007,6 ( 2 ) : 109 - 110.
  • 4DOOSEOP K, LIPING W, MARIA B. (2R) -4-0xo-4-[ 3-(Trif- luoromethyl) -5,6-dihydro [ 1,2,4 ] triazolo [ 4, 3-a pyrazin-7 (8H) -yl ] -1 - ( 2,4,5-trifluorophenyl ) butan-2-amine : a Potent, Orally Active Dipeptldyl Peptldase IV Inhibitor for the Treatment of Type2 Diabetes[J]. JMed Chem, 2005(48): 141 -151.
  • 5HANSEN KB, BALSELLS J, DREHER S, et al. First genera- tion Proeess for the preparation of the Dpp-IV inhibitor sitagliptin [J]. Org Pro Res Dev,2005, 9(5) : 634 -639.
  • 6DREHER SD, IKEMOTO N, NJOLITO E, et al. Proeess to ehiral 13-amino acid derivatives. WO: 2004085661 [ P ]. 2004 -10 - 07.
  • 7LIU F,YU WS, OU WH, et al. The synthesis of a chiral-amino acid derivative by the Grignard reaction of an aspartlc acid equiv- alent[J]. JChemRes, 2010, 34(9): 517 -519.
  • 8CHEN J, ZHANG W, GENG H. Efficient synthesis of chiral b- Arylisopropylamines by Using Catalytic Asymmetric Hydrogena- tion [ J ]. Angew Chem Int Ed Engl, 2009, 48 (4) : 800 - 802.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部